05:53:08 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



MIV Therapeutics says U.S. judgment not enforceable

2012-02-20 14:20 ET - Street Wire

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

MIV Therapeutics Inc., a Vancouver pink sheets listing, claims that a $547,091 judgment against it in Massachusetts was obtained by fraud and should not be enforced by the Supreme Court of British Columbia. (All figures are in U.S. dollars.) MIV says a U.S. patent firm that obtained the judgment did so without providing any notice to the company.

The Massachusetts decision against MIV arose from work that a Boston patent firm, Rissman Hendricks & Oliverio LLP, claimed to have done for the company. Rissman said that it provided two years of legal services and disbursed over $80,000 of its own money to maintain MIV's patent portfolio, but was never paid. The firm obtained the judgment against MIV in Massachusetts on Dec. 22, 2011, and filed a lawsuit in B.C. seeking to enforce that decision.

In response to the B.C. suit, MIV says that it was not notified that Rissman was seeking any judgment in Massachusetts. It acknowledges that it was facing legal action in the state, but says it attempted to negotiate a settlement. MIV claims it was unaware that Rissman had asked for a judgment in the case.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed